54.80NOK+1.11%Mkt Cap: —P/E: —1d ago
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and De…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value123.58M $
Revenue (TTM)63.45M $
Gross Profit59.38M $
Net Income (TTM)7.36M $
Revenue/Share2.371 USD
Last Price54.80 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA10.19
EV/Revenue1.95
P/S—
P/B2.43
EPS (TTM)-2.53
EPS (Forward)—
52W Range
54.2018% of range57.50
52W High57.50 NOK
52W Low54.20 NOK
Profitability
Gross Margin93.59%
Oper. Margin-6.59%
EBITDA Margin19.11%
Profit Margin11.60%
ROE14.49%
ROA8.56%
Growth
Revenue Growth5.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF9.16M $
CapEx (TTM)—
FCF Margin1.86%
FCF Yield—
Net Debt-14.30M $
Net Debt/EBITDA-1.18
Balance Sheet
Debt/Equity1.55
Current Ratio3.65
Quick Ratio3.11
Book Value/Sh22.54 NOK
Cash/Share6.034 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.21.58M
Float20.33M
Insiders3.58%
Institutions37.97%
Technical
SMA 5062.62 (-12.5%)
SMA 20053.83 (+1.8%)
Beta0.34
S&P 52W Chg18.16%
Avg Vol (30d)580
Avg Vol (10d)455
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—